These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Quantification of the role of temporal artery biopsy in diagnosing clinically suspected giant cell arteritis. Varma D, O'Neill D. Eye (Lond); 2004 Apr; 18(4):384-8. PubMed ID: 15069435 [Abstract] [Full Text] [Related]
5. Validity of the American College of Rheumatology criteria for the diagnosis of giant cell arteritis. Murchison AP, Gilbert ME, Bilyk JR, Eagle RC, Pueyo V, Sergott RC, Savino PJ. Am J Ophthalmol; 2012 Oct; 154(4):722-9. PubMed ID: 22809782 [Abstract] [Full Text] [Related]
14. Assessment of the cranial involvement pattern of giant cell arteritis with 3T magnetic resonance imaging. Bley TA, Weiben O, Uhl M, Vaith P, Schmidt D, Warnatz K, Langer M. Arthritis Rheum; 2005 Aug; 52(8):2470-7. PubMed ID: 16052572 [Abstract] [Full Text] [Related]
16. The clinical utility of high resolution magnetic resonance imaging in the diagnosis of giant cell arteritis: a critically appraised topic. Khoury JA, Hoxworth JM, Mazlumzadeh M, Wellik KE, Wingerchuk DM, Demaerschalk BM. Neurologist; 2008 Sep; 14(5):330-5. PubMed ID: 18784606 [Abstract] [Full Text] [Related]
17. Prevalence of a normal C-reactive protein with an elevated erythrocyte sedimentation rate in biopsy-proven giant cell arteritis. Parikh M, Miller NR, Lee AG, Savino PJ, Vacarezza MN, Cornblath W, Eggenberger E, Antonio-Santos A, Golnik K, Kardon R, Wall M. Ophthalmology; 2006 Oct; 113(10):1842-5. PubMed ID: 16884778 [Abstract] [Full Text] [Related]